4
Changes in Ownership
TEVA PHARMACEUTICAL INDUSTRIES LTD Filed Acc 0001209191-21-032252
Executive VP, Global R&D sold 19,066 shares at $10.22 ($194,830)
- Executive VP, Global R&D acquired 37,884 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fridriksdottir Hafrun Executive VP, Global R&D | 2021-05-11 | Option exercise | +37,884 | 111,337.51 | D | ||
| Fridriksdottir Hafrun Executive VP, Global R&D | 2021-05-11 | Sale | −19,066 | $10.22 | $194,830 | 92,271.51 | D |
| Derivatives | |||||||
| Fridriksdottir Hafrun Executive VP, Global R&D | 2021-05-11 | Option exercise · Restricted Share Units | −37,884 | 0 | D | ||
| Open-market sales · 19,066 sh · avg $10.22 · $194,830 | |||||||
Loading xslF345X03/doc4.xml…